Anti-neurofascin demyelinating diseases
Jump to navigation
Jump to search
 | This article needs more medical references for verification or relies too heavily on primary sources, specifically: It relies too much on primary sources. (June 2022) |  |
Anti-neurofascin demyelinating diseases (anti-NF diseases) refers to health conditions engendered by auto-antibodies against neurofascins, which can produce both central and peripheral demyelination. Some cases of combined central and peripheral demyelination (CCPD) could be produced by them.[1][non-primary source needed]
- Chronic inflammatory demyelinating polyneuropathy: Some cases of CIDP are reported to be produced by auto-antibodies against several neurofascin proteins. These proteins are present in the neurons and four of them have been reported to produce disease: NF186, NF180, NF166 and NF155.[2]
- Neuromyelitis optica: NF auto antibodies can also appear in NMO cases.[2] These antibodies are more related to the peripheral nervous demyelination, but they were also found in NMO.[3][non-primary source needed]
- Multiple sclerosis: Also antibodies against Neurofascins NF-155 can also appear in atypical multiple sclerosis[4] and NF-186 could be involved in subtypes of MS[5] yielding an intersection between both conditions. Around 10% of MS cases are now thought to be anti-NF cases.[6][7]
History
The first report about a subgroup of MS patients with anti-NF and contactin 2 auto-antibodies was published in 2011[8]
References
- ^ Ciron, Jonathan; Carra-Dallière, Clarisse; Ayrignac, Xavier; Neau, Jean-Philippe; Maubeuge, Nicolas; Labauge, Pierre (3 November 2018). "The coexistence of recurrent cerebral tumefactive demyelinating lesions with longitudinally extensive transverse myelitis and demyelinating neuropathy". Multiple Sclerosis and Related Disorders. 27: 223–225. doi:10.1016/j.msard.2018.11.002. ISSN 2211-0348. PMID 30414563. S2CID 53292167.
- ^ a b Kira, Jun-ichi; Yamasaki, Ryo; Ogata, Hidenori (2019-11-01). "Anti-neurofascin autoantibody and demyelination". Neurochemistry International. Emerging focus areas in Neuroimmunology. 130: 104360. doi:10.1016/j.neuint.2018.12.011. ISSN 0197-0186. PMID 30582947. S2CID 56595020.
- ^ Jia, Kun; Zhang, Xu; Zhang, Lin-Jie; Li, Li-Min; Qi, Yuan; Yi, Ming; Zhang, Chao; Yang, Chun-Sheng; Yang, Li (16 January 2019). "Anti-neurofascin-155 antibody-positive neuromyelitis optica spectrum disorders". Journal of the Neurological Sciences. 398: 16–18. doi:10.1016/j.jns.2019.01.024. ISSN 0022-510X. PMID 30665067. S2CID 58636411.
- ^ Stich O, Perera S, Berger B, Jarius S, Wildemann B, Baumgartner A, Rauer S (March 2016). "Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis". Journal of the Neurological Sciences. 364: 29–32. doi:10.1016/j.jns.2016.03.004. PMID 27084211. S2CID 29204735.
- ^ "Multiple Sclerosis Society Website - Welcome to the MS Society - lini…". archive.ph. 2007-06-21. Retrieved 2022-06-29.
- ^ Goncalves, Marcus Vinicius Magno; Fragoso, Yara Dadalti (2019-04-08). "The involvement of anti-neurofascin 155 antibodies in central and peripheral demyelinating diseases". Neuroimmunology and Neuroinflammation. 6: 6. doi:10.20517/2347-8659.2019.08. ISSN 2347-8659. S2CID 146038130.
- ^ Kawamura, Nobutoshi; Yamasaki, Ryo; Yonekawa, Tomomi; Matsushita, Takuya; Kusunoki, Susumu; Nagayama, Shigemi; Fukuda, Yasuo; Ogata, Hidenori; Matsuse, Dai; Murai, Hiroyuki; Kira, Jun-ichi (2013-08-20). "Anti-neurofascin antibody in patients with combined central and peripheral demyelination". Neurology. 81 (8): 714–722. doi:10.1212/WNL.0b013e3182a1aa9c. ISSN 0028-3878. PMID 23884033. S2CID 20359260.
- ^ Meinl, Edgar; Derfuss, Tobias; Krumbholz, Markus; Pröbstel, Anne-Katrin; Hohlfeld, Reinhard (6 September 2010). "Humoral autoimmunity in multiple sclerosis". Journal of the Neurological Sciences. 306 (1–2): 180–182. doi:10.1016/j.jns.2010.08.009. ISSN 0022-510X. PMID 20817206. S2CID 22349060.
 | This neuroscience article is a stub. You can help Justapedia by expanding it. |